Belpointe Asset Management LLC Selecta Biosciences Inc Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$0.67 - $1.35 $1,340 - $2,700
2,000 Added 7.58%
28,400 $19,000
Q3 2023

Nov 15, 2023
BUY
$1.02 - $1.23 $26,928 - $32,472
26,400 New
26,400 $27,000
Q1 2023

May 15, 2023
BUY
$1.15 - $1.89 $1,035 - $1,701
900 Added 10.31%
9,631 $13,000
Q4 2022

Feb 08, 2023
BUY
$0.96 - $1.6 $8,381 - $13,969
8,731 New
8,731 $9,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email